Khandelwal Laboratories Pvt., Ltd. develops, manufactures, markets, out-licenses, and sells pharmaceutical formulations, novel drug delivery systems, APIs, and chiral intermediates in India and internationally. It manufactures products in the areas of oncology, antibiotics, and pain and spasm management. The company’s products include tablets, capsules, powders, and liquid injections; and cephalosporin, metal nano particles, and bulk drugs. It also develops the chiral pools of carbohydrates, monosaccharides, amino alcohols, and oxazolidines; dendrimer systems for cosmetic and drug delivery applications; generic products in various therapeutic segments; and dendrite technologies. In addition, the company provides contract manufacturing services for pharmaceutical companies; and clinical research services for contract research organizations, site management organizations, and pharmaceutical companies. It serves gastroenterologists, general physicians, orthopaedicians, surgeons, pediatricians, diabetologists, cardiologists, chest physicians, gynecologists, pharmacies, institutions, and stockists.